Genetic testing for cancer risk

Actionable Insights Powered by AI

23andMe Restructures, Cuts 40% of Workforce and Ends Therapeutics Division Amid Financial Struggles

23andMe, layoffs, therapeutics division, financial struggles, genetic testing, data security